Cargando…

Understanding the benefits and risks of pharmaceuticals : workshop summary, Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy /

Detalles Bibliográficos
Clasificación:	Libro Electrónico
Autor Corporativo:	Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation
Otros Autores:	Pray, Leslie A.
Formato:	Electrónico eBook
Idioma:	Inglés
Publicado:	Washington, D.C. : National Academies Press, ©2007.
Temas:	Drugs > Congresses. Drugs > Side effects > Congresses. Chemotherapy > Congresses. Chemotherapy > Side effects > Congresses. Drugs. Drugs > Side effects. Chemotherapy. Risk assessment. Pharmaceutical Preparations Drug-Related Side Effects and Adverse Reactions Drug Therapy Risk Assessment Médicaments > Congrès. Médicaments > Effets secondaires > Congrès. Chimiothérapie > Congrès. Chimiothérapie > Effets secondaires > Congrès. Médicaments. Médicaments > Effets secondaires. Chimiothérapie. Évaluation du risque. risk assessment. MEDICAL > Drug Guides. MEDICAL > Pharmacology. MEDICAL > Pharmacy. MEDICAL > Nursing > Pharmacology. Chemotherapy Drugs Drugs > Side effects Congress proceedings (reports) Conference papers and proceedings Conference papers and proceedings. Actes de congrès. Electronic books.
Acceso en línea:	Texto completo

MARC


LEADER	00000cam a2200000 a 4500
001	EBOOKCENTRAL_ocn298790805
003	OCoLC
005	20240329122006.0
006	m o d
007	cr cn\|\|\|\|\|\|\|\|\|
008	090112s2007 dcua ob 100 0 eng d
010			\|z 2009368273
040			\|a CaPaEBR \|b eng \|e pn \|c CUY \|d OCLCQ \|d N$T \|d YDXCP \|d COF \|d OCLCQ \|d DKDLA \|d ADU \|d E7B \|d GPM \|d CDS \|d CU3 \|d OCLCQ \|d OCLCO \|d OCLCQ \|d COO \|d OCLCA \|d OCLCQ \|d OCLCO \|d NLGGC \|d OCLCQ \|d OCLCO \|d EBLCP \|d OCLCQ \|d OCLCO \|d OCLCQ \|d AZK \|d LOA \|d OCLCO \|d OCLCA \|d TOA \|d OCLCO \|d AGLDB \|d CNNOR \|d UAB \|d MOR \|d PIFBR \|d OCLCQ \|d ZCU \|d MERUC \|d OCLCQ \|d MERER \|d OCLCO \|d OCLCA \|d U3W \|d OCLCA \|d BUF \|d OCLCO \|d CUY \|d OCLCQ \|d OCLCF \|d OCLCO \|d BRL \|d STF \|d OCLCO \|d WRM \|d VNS \|d OCLCO \|d OCLCQ \|d VTS \|d OCLCO \|d NRAMU \|d EZ9 \|d OCLCQ \|d ICG \|d OCLCO \|d VT2 \|d OCLCQ \|d OCLCO \|d WYU \|d OCLCO \|d OCLCA \|d OCLCQ \|d A6Q \|d DKC \|d OCLCO \|d OCLCQ \|d M8D \|d UKAHL \|d OCLCQ \|d OCLCA \|d OCLCQ \|d OCLCO \|d CFI \|d TUHNV \|d OCLCA \|d OCLCO \|d OCLCQ \|d SDF \|d OCLCO \|d INARC \|d OCLCL
016	7		\|a 101392594 \|2 DNLM
019			\|a 174031020 \|a 475738439 \|a 476019951 \|a 614468521 \|a 647663874 \|a 888841136 \|a 923277273 \|a 961556030 \|a 962616074 \|a 965994899 \|a 988437122 \|a 991937628 \|a 1037504521 \|a 1037922745 \|a 1038649882 \|a 1045562936 \|a 1046994170 \|a 1055331699 \|a 1058981491 \|a 1062880370 \|a 1081258977 \|a 1083605044 \|a 1097149667 \|a 1156390398 \|a 1200859549 \|a 1228548509 \|a 1249232679 \|a 1412760905
020			\|a 9780309107396 \|q (electronic bk.)
020			\|a 0309107393 \|q (electronic bk.)
020			\|z 9780309107389
020			\|z 0309107385
029	1		\|a AU@ \|b 000044592012
029	1		\|a AU@ \|b 000051534867
029	1		\|a AU@ \|b 000053252365
029	1		\|a AU@ \|b 000060528699
029	1		\|a DEBBG \|b BV043158376
029	1		\|a DEBBG \|b BV044108717
029	1		\|a DEBSZ \|b 42217825X
029	1		\|a GBVCP \|b 802755194
029	1		\|a NZ1 \|b 14238085
035			\|a (OCoLC)298790805 \|z (OCoLC)174031020 \|z (OCoLC)475738439 \|z (OCoLC)476019951 \|z (OCoLC)614468521 \|z (OCoLC)647663874 \|z (OCoLC)888841136 \|z (OCoLC)923277273 \|z (OCoLC)961556030 \|z (OCoLC)962616074 \|z (OCoLC)965994899 \|z (OCoLC)988437122 \|z (OCoLC)991937628 \|z (OCoLC)1037504521 \|z (OCoLC)1037922745 \|z (OCoLC)1038649882 \|z (OCoLC)1045562936 \|z (OCoLC)1046994170 \|z (OCoLC)1055331699 \|z (OCoLC)1058981491 \|z (OCoLC)1062880370 \|z (OCoLC)1081258977 \|z (OCoLC)1083605044 \|z (OCoLC)1097149667 \|z (OCoLC)1156390398 \|z (OCoLC)1200859549 \|z (OCoLC)1228548509 \|z (OCoLC)1249232679 \|z (OCoLC)1412760905
050		4	\|a RM300 \|b .U53 2007eb
060		4	\|a QV 55 \|b U55 2007eb
072		7	\|a MED \|x 023000 \|2 bisacsh
072		7	\|a MED \|x 071000 \|2 bisacsh
072		7	\|a MED \|x 072000 \|2 bisacsh
072		7	\|a MED \|x 058170 \|2 bisacsh
082	0	4	\|a 615/.1 \|2 22
049			\|a UAMI
245	0	0	\|a Understanding the benefits and risks of pharmaceuticals : \|b workshop summary, Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy / \|c Leslie Pray, rapporteur ; Institute of Medicine of the National Academies.
246	3	0	\|a Benefits and risks of pharmaceuticals
246	3	0	\|a Forum on Drug Discovery, Development, and Translation
260			\|a Washington, D.C. : \|b National Academies Press, \|c ©2007.
300			\|a 1 online resource (xi, 85 pages) : \|b illustrations
336			\|a text \|b txt \|2 rdacontent
337			\|a computer \|b c \|2 rdamedia
338			\|a online resource \|b cr \|2 rdacarrier
347			\|a data file
504			\|a Includes bibliographical references.
505	0		\|a Regulatory assessment -- The challenge of communication -- The importance of context in healthcare decision making -- Patient experience with drugs over time -- Next steps.
588	0		\|a Print version record.
590			\|a ProQuest Ebook Central \|b Ebook Central Academic Complete
650		0	\|a Drugs \|v Congresses.
650		0	\|a Drugs \|x Side effects \|v Congresses.
650		0	\|a Chemotherapy \|v Congresses.
650		0	\|a Chemotherapy \|x Side effects \|v Congresses.
650		0	\|a Drugs.
650		0	\|a Drugs \|x Side effects.
650		0	\|a Chemotherapy.
650		0	\|a Risk assessment.
650		2	\|a Pharmaceutical Preparations
650	1	2	\|a Drug-Related Side Effects and Adverse Reactions
650		2	\|a Drug Therapy
650		2	\|a Risk Assessment
650		6	\|a Médicaments \|v Congrès.
650		6	\|a Médicaments \|x Effets secondaires \|v Congrès.
650		6	\|a Chimiothérapie \|v Congrès.
650		6	\|a Chimiothérapie \|x Effets secondaires \|v Congrès.
650		6	\|a Médicaments.
650		6	\|a Médicaments \|x Effets secondaires.
650		6	\|a Chimiothérapie.
650		6	\|a Évaluation du risque.
650		7	\|a risk assessment. \|2 aat
650		7	\|a MEDICAL \|x Drug Guides. \|2 bisacsh
650		7	\|a MEDICAL \|x Pharmacology. \|2 bisacsh
650		7	\|a MEDICAL \|x Pharmacy. \|2 bisacsh
650		7	\|a MEDICAL \|x Nursing \|x Pharmacology. \|2 bisacsh
650		7	\|a Chemotherapy \|2 fast
650		7	\|a Drugs \|2 fast
650		7	\|a Drugs \|x Side effects \|2 fast
655		2	\|a Congress
655		7	\|a proceedings (reports) \|2 aat
655		7	\|a Conference papers and proceedings \|2 fast
655		7	\|a Conference papers and proceedings. \|2 lcgft
655		7	\|a Actes de congrès. \|2 rvmgf
655		0	\|a Electronic books.
700	1		\|a Pray, Leslie A.
710	2		\|a Institute of Medicine (U.S.). \|b Forum on Drug Discovery, Development, and Translation.
758			\|i has work: \|a Understanding the benefits and risks of pharmaceuticals (Text) \|1 https://id.oclc.org/worldcat/entity/E39PCFBgkMfBBfHhDmtWWpXjRX \|4 https://id.oclc.org/worldcat/ontology/hasWork
776	0	8	\|i Print version: \|t Understanding the benefits and risks of pharmaceuticals. \|d Washington, D.C. : National Academies Press, ©2007 \|z 9780309107389 \|z 0309107385 \|w (OCoLC)166869493
856	4	0	\|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=3378272 \|z Texto completo
936			\|a BATCHLOAD
938			\|a Askews and Holts Library Services \|b ASKH \|n AH36616803
938			\|a Askews and Holts Library Services \|b ASKH \|n AH36557957
938			\|a ProQuest Ebook Central \|b EBLB \|n EBL3378272
938			\|a EBSCOhost \|b EBSC \|n 205582
938			\|a YBP Library Services \|b YANK \|n 2716183
938			\|a Internet Archive \|b INAR \|n isbn_9780309107389
994			\|a 92 \|b IZTAP

Understanding the benefits and risks of pharmaceuticals : workshop summary, Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy /

MARC

Ejemplares similares